Researchers have identified three gene abnormalities that appear to raise the likelihood for developing the thyroid cancer, with one in particular -- the PTEN gene -- implicated in children’s risk for the disease. Dr. Charis Eng, founding director of the Genomic Medicine Institute of Cleveland Clinic’s Lerner Research Institute, said in a news release that her team’s “investigation into the genetics behind thyroid disease raises important details relevant to diagnosis and treatment. We hope to promote the earliest diagnosis and most targeted treatment possible.”
